ABBOTT PARK, Ill., Dec. 17, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved updated labeling for the company's HeartMate 3™ heart pump ...
The field of pediatric mechanical circulatory support with ventricular assist devices has lagged significantly behind that of adult patients. However, there is increasing attention on the emerging ...
"This is a landmark event for children suffering from terminal heart failure." Charles D. Fraser, Jr., MD, Texas Children’s Hospital THE WOODLANDS, Tex., and BERLIN, Dec. 16, 2011—The Berlin Heart ...
Please provide your email address to receive an email when new articles are posted on . The first prospective FDA-regulated device trial using a pediatric ventricular assist device registry was ...
THE WOODLANDS, Texas--(BUSINESS WIRE)--Berlin Heart Inc. announced they have completed the Post Approval Surveillance for the EXCOR ® Pediatric Ventricular Assist Device, a requirement of the Post ...
HOUSTON – Jan.18, 2008 --Texas Children’s Hospital has been named the national lead center for a 12-hospital, 36-month clinical trial of the German-manufactured pediatric heart pump called Berlin ...
The trial was a prospective, multi-center, single-arm cohort study. Children implanted with the EXCOR® Pediatric VAD as a bridge to cardiac transplantation were compared to a historical control group ...
VADs are usually classified according to the mode of blood flow, namely pulsatile or continuous. Continuous types can be further subdivided based on the biomechanics of the pump: centrifugal or axial.
THE WOODLANDS, Texas--(BUSINESS WIRE)--Berlin Heart Inc. announced they have completed the Post Approval Surveillance for the EXCOR ® Pediatric Ventricular Assist Device, a requirement of the Post ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results